Overview

Impact of P53 and SIRT1 in Type 2 Diabetes

Status:
Recruiting
Trial end date:
2028-12-01
Target enrollment:
Participant gender:
Summary
Investigating the impact of p53 and SIRT1 in the development of type 2 DM
Phase:
Phase 3
Details
Lead Sponsor:
Sherief Abd-Elsalam
Treatments:
Metformin